Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112480197B reveals a cost-effective route for cytosine nucleoside using cyanoacetaldehyde urea acetal, offering significant supply chain advantages.
Novel McMurry reaction method for triphenylbutene derivatives offering improved yield and safety for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN101497639B details a scalable Decitabine synthesis using toluoyl protection and fractional crystallization, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN112812060B reveals a metal-free, visible-light driven arylation method for tetrahydroquinoline derivatives, offering green synthesis routes for pharmaceutical intermediates.
Novel patent CN115925598B enables safe thiofluoroformamide production without toxic gases offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Novel 6-step synthesis for GalNAc analogues offers high purity and scalable production. Ideal for siRNA conjugates and liver targeting delivery systems.
Patent CN111925335B reveals a base-catalyzed route for 5-amino-1,2,3-triazoles, eliminating expensive metals and toxic azides for safer, scalable pharmaceutical manufacturing.
Advanced Pd-catalyzed route for Palbociclib Intermediate II. High yield, cost-effective process for API manufacturing.
Patent CN102766004B reveals a one-step copper-catalyzed method for aminoacyl arylamine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN103665064B details a novel three-step synthesis for high-purity sugar intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN113388852B reveals a green electrochemical method for pyrido purine synthesis, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.
Discover the patented CN102146022A method for 3-chloro-5-bromophenol. Achieve high purity and cost reduction in fine chemical manufacturing with our scalable route.
Patent CN110054589B reveals a cost-effective copper-catalyzed route for benzoquinoline esters, offering significant supply chain advantages for API manufacturing.
Patent CN103664911B reveals metal catalytic coupling for Vilazodone intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel palladium-catalyzed decarboxylative [5+3] cycloaddition patent offers high enantioselectivity and mild conditions for scalable pharmaceutical intermediates manufacturing supply chain.
Patent CN102452981A reveals novel synthesis of 1,3-disubstituted-3-azabicyclo[3,2,1]octanes, offering cost-effective routes for pharmaceutical intermediate manufacturing and supply chain optimization.
Novel phosphonylation method for fosaprepitant dimeglumine intermediate. Enhances yield, purity, and supply chain reliability for global pharmaceutical manufacturing partners.
Advanced preparation of c-Met inhibitor intermediates via Pd-catalyzed coupling. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN105399663A offers high purity 2,3-dichloropyridine with cost effective manufacturing process for reliable supply chain partners.
Patent CN115304465B reveals green carbonyl synthesis. Reduces toxic waste and enhances supply chain reliability for global pharmaceutical intermediates manufacturing.